Article
Author(s):
We're trying to make our stress tests more realistic.
Details Behind the Phase 3 MyClad Study of Cladribine in Myasthenia Gravis
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
New Published Guideline Provides Recommendations for Primary Stroke Prevention Across Life Span
Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis
This Week on NeurologyLive® — October 21, 2024
Subcutaneous Efgartigimod PH20 Efficacious in Patients With CIDP Previously Treated